HRMY (Harmony Biosciences Holdings) Insider Ownership: 0.54 % (As of Sep. 10, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HRMY Harmony Biosciences Holdings Inc HRMY
96 GF Score
Price $41.10
GF Value $47.14
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is Harmony Biosciences Holdings Insider Ownership?

Harmony Biosciences Holdings HRMY -1.25% 96 Insider Ownership is 0.54 % as of Sep. 10, 2026. GuruFocus rates HRMY with a GF Score™ of 96/100 and a GF Value™ of $47.14 (Modestly Undervalued). The stock has 4 warning signs investors should review.

Insider ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Harmony Biosciences Holdings's insider ownership is 0.54%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Harmony Biosciences Holdings's Institutional Ownership is 93.28%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Harmony Biosciences Holdings's Float Percentage Of Total Shares Outstanding is 74.87%.

Harmony Biosciences Holdings Insider Ownership Historical Data

* Premium members only.

The historical data trend for Harmony Biosciences Holdings's Insider Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Harmony Biosciences Holdings Insider Ownership Chart

Harmony Biosciences Holdings Historical Data

The historical data trend for Harmony Biosciences Holdings can be seen below:

2025-08-31 2025-09-30 2025-10-31 2025-11-30 2026-01-31 2026-02-28 2026-05-31 2026-06-30 2026-07-31 2026-08-31
Insider Ownership 0.47 0.47 0.51 0.47 0.50 0.50 0.54 0.54 0.55 0.54
HRMY
96GF Score
Harmony Biosciences Holdings Inc HRMY
Insider Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Harmony Biosciences Holdings Insider Ownership Calculation

The percentage of shares that are owned by company insiders relative to the total shares outstanding.

Frequently Asked Questions Learn more about Insider Ownership →
What does a Insider Ownership of 0.54 % mean?
Harmony Biosciences Holdings (HRMY) has a Insider Ownership of 0.54 % as of Sep. 10, 2026. Insider ownership equals the percent of shares owned by company insiders relative to total shares. View historical data on Harmony Biosciences Holdings and its competitors.
Is Harmony Biosciences Holdings' Insider Ownership too high?
Harmony Biosciences Holdings' current Insider Ownership is 0.54 %. Overall, Harmony Biosciences Holdings has a GF Score™ of 96/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Harmony Biosciences Holdings' Insider Ownership compare to OCUL and MLYS?
Harmony Biosciences Holdings' Insider Ownership of 0.54 % can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Insider Ownership for a Biotechnology company?
A good Insider Ownership depends on the Biotechnology industry context. However, Insider Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Insider Ownership mean?
A high Insider Ownership can signal that a stock is expensive relative to its fundamentals. Insider ownership equals the percent of shares owned by company insiders relative to total shares. View historical data on Harmony Biosciences Holdings and its competitors. Harmony Biosciences Holdings's current Insider Ownership is 0.54 %. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Harmony Biosciences Holdings stock overvalued right now?
Based on GuruFocus' analysis, Harmony Biosciences Holdings (HRMY) is currently considered Modestly Undervalued. The stock's GF Value™ is $47.14, compared to a current price of $41.10 — trading 12.8% below its estimated fair value. The current Insider Ownership is 0.54 %. Harmony Biosciences Holdings' overall GF Score™ is 96/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Insider Ownership calculated?
Insider Ownership is calculated from a company's financial statements. For Harmony Biosciences Holdings (HRMY), the current Insider Ownership is 0.54 % as of Sep. 10, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Harmony Biosciences Holdings (HRMY) Overvalued in 2026?

Based on GuruFocus' analysis, Harmony Biosciences Holdings stock appears to be undervalued. The current stock price of $41.10 is trading 12.8% below its estimated GF Value™ of $47.14. GuruFocus considers Harmony Biosciences Holdings to be Modestly Undervalued.

Key valuation signals for HRMY:

  • Insider Ownership: 0.54 %
  • GF Value™: $47.14 vs. price of $41.10 (12.8% below fair value)
  • GF Score™: 96/100 with 4 warning signs

No single metric tells the full story. See the HRMY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Harmony Biosciences Holdings Business Description

Address 630 W. Germantown Pike, Suite 215, Plymouth Meeting, PA, USA, 19462
Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company has one reportable segment: rare neurological diseases. Its product WAKIX (pitolisant) is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and is used for the treatment of cataplexy in adult patients with narcolepsy. The other drug candidates in its pipeline are Pitolisant, HBS-102 (MCHR1 antagonist), BP1.15205 (orexin-2 receptor agonist), ZYN002 (cannabidiol gel), EPX-100 (clemizole hydrochloride), and EPX-200 (lorcaserin), among others.
96GF Score

Get the complete analysis for HRMY

Insider Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$41.10
Price
$47.14
GF Value